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This study evaluated relationships between irritable bowel syndrome (IBS) pain, sympathetic dysregulation, and thermal pain
sensitivity. Eight female patients with diarrhea-predominant IBS and ten healthy female controls were tested for sensitivity to
thermal stimulation of the left palm. A new method of response-dependent thermal stimulation was used to maintain pain
intensity at a predetermined level (35%) by adjusting thermal stimulus intensity as a function of pain ratings. Clinical pain
levels were assessed prior to each testing session. Skin temperatures were recorded before and after pain sensitivity testing.
The temperature of palmar skin dropped (1.5◦C) when the corresponding location on the opposite hand of control subjects
was subjected to prolonged thermal stimulation, but this response was absent for IBS pain patients. The patients also required
signiﬁcantly lower stimulus temperatures than controls to maintain a 35% pain rating. Baseline skin temperatures of patients were
signiﬁcantlycorrelatedwiththermodetemperaturesrequiredtomaintain35%painratings.IBSpainintensitywasnotsigniﬁcantly
correlatedwithskintemperatureorpainsensitivity.Themethodofresponse-dependentstimulationrevealedthermalhyperalgesia
and increased sympathetic tone for chronic pain patients, relative to controls. Similarly, a signiﬁcant correlation between resting
skin temperatures and thermal pain sensitivity for IBS but not control subjects indicates that tonic sympathetic activation and a
thermal hyperalgesia were generated by the chronic presence of visceral pain. However, lack of a signiﬁcant relationship between
sympathetictoneandratingsofIBSpaincastsdoubtonpropositionsthatthemagnitudeofIBSpainisdeterminedbypsychological
stress.
1.Introduction
Irritable bowel syndrome (IBS) is a functional pain dis-
order with no known etiology but an association with
psychological stress [1–3]. Because autonomic output sys-
tems of central stress circuits control essential functions
of the gut [4–6], stress has been suspect as a cause of
IBS [1, 5, 7]. Levels of stress can be revealed as increased
sympathetic and/or decreased parasympathetic activity, and
IBS patients often have enhanced sympathetic activation
[8–14] or reduced parasympathetic activation [8, 14–19]
and/or an increased sympathetic/parasympathetic ratio [14,
17, 19, 20]. Numerous factors can change relationships
between diagnoses of IBS and levels of autonomic activation
including age, duration of chronic pain, gender, proﬁles of
gut disturbance (e.g., abdominal pain with constipation or
diarrhea), magnitude of IBS pain, skin temperature, and the
method of autonomic stimulation.
Correlations between autonomic dysregulation and IBS
should not be construed to establish stress as a cause of2 Pain Research and Treatment
abdominal pain, because pain is a potent source of stress
and therefore of sympathetic activation [10, 21–23], which
can increase pain sensitivity [10, 24, 25]. Thus, pain from
pathological processing within the gut generates stress, and
stress can increase pain produced by stimulation of the
gut [5, 26, 27], setting up a vicious cycle. Relationships
between the presence of pain and autonomic dysfunction
in IBS patients have been shown in models that used blood
pressure, heart rate variability, and heart rate as indicators
[10, 28, 29]. Visceral (rectal distention) and repeated large
area somatic (foot immersion in a hot water bath) stimuli
were used to evoke the responses. In the present study,
we hypothesize that abnormal autonomic responsivity (skin
thermoregulation) can be revealed by prolonged focal ther-
mocutaneous stimulation. Several minutes long episodes of
thermocutaneous pain were induced with a new stimulation
method that makes the procedure safe and tolerable for the
subjects [30].
We evaluated clinical pain levels of female IBS patients
with diarrhea. IBS is more prevalent among females than
males [31], and females are particularly susceptible to stress-
related pain conditions [32]. Females have been charac-
terized in terms of resting parasympathetic dominance,
compared to males [33], and according to some studies
IBS patients with diarrhea are especially prone to sym-
pathetic dysregulation [10, 34–37]. These characteristics
should maximize detection of sympathetic activation for
comparison with levels of IBS pain. Skin temperature was
selected as a sensitive measure of sympathetic activation for
females [13, 25, 38, 39]. Painful thermal stimulation was
chosen as a method of phasic autonomic activation, because
the impact of this procedure could be quantiﬁed as the
magnitude of elicited pain, which could be related to skin
temperatures.
2. Methods
2.1. Subjects. The subjects were eight female IBS patients
that were diagnosed with diarrhea-predominant IBS (age
range of 21–53; mean age of 36.3 years) and ten healthy
female controls (age range of 19–45; mean age of 27.0 years).
Written informed consent was obtained from all participants
once the nature of the study had been thoroughly explained.
The procedures were conducted under approval of the
University of Florida Institutional Review Board and the
Veterans Administration SCI committee.
The criteria for members of the control group required
no signiﬁcant spontaneous pain anywhere in the body, no
ongoing pharmacotherapy with narcotics or antidepressants,
and no disease that might signiﬁcantly aﬀect pain perception
orundulyincreaseriskofinjury(e.g.,neurologicaldisorders,
serious psychiatric disorders, diabetes, hypertension, serious
cardiovascular disorders, and chronic pain diseases such as
ﬁbromyalgia syndrome). The criteria for the disease group
required a diagnosis of ongoing IBS based upon the Rome II
criteria [40], supplemented by additional criteria—absence
of other diseases (including other chronic pain diseases), risk
factors, and ongoing drug treatments—as described for the
control group. Patients with any condition where sponta-
neous pain was widespread, according to the deﬁnition of
the American College of Rheumatology [41], were excluded
from the study. This ruled out participation of subjects that
met the ACR diagnostic criteria for ﬁbromyalgia syndrome.
Initial screening consisted of blood pressure measurement,
completion of a health questionnaire, and for IBS patients,
clinical diagnosis by a physician. All of the patients reported
recent and recurring episodes of spontaneous abdominal
pain or discomfort. All subjects were right-handed.
2.2. Response-Dependent Thermal Stimulation. The subjects
were asked to rate pain intensity continuously by making
adjustments to the slider of an electronic visual analog scale
(eVAS).Instructionsregardingtheuseofthescaleanditsend
points (“no pain” and “intolerably intense pain”) were given
by a standardized video. The slider’s position was recorded as
a percentage of its total travel. The eVAS was mounted into
the surface of a small inclined desk, which was positioned
to facilitate precise operation with minimal fatigue. During
the entire experiment, the subject was separated from the
investigator by an equipment rack and was facing away to
minimize nonverbal communication and transmission of
bias.
Thermal stimuli were administered with a ﬂat copper
contact thermode 23 × 23mm in size. The thermode
was electronically held at the desired temperature by a
Peltier thermoelectric device. It was brought into light skin
contact of reproducible force by solenoid activation. Control
software for the stimulator sampled pain intensity ratings
to make automatic adjustments in thermode temperature to
maintain an average pain rating that equaled a set point of
35%(35onaVASscaleof0–100).Thedependentvariablefor
response-dependent stimulation was the thermode tempera-
ture, and high pain sensitivity was revealed by a low average
thermode temperature [30].
Four series of 25 brief thermal contact pulses each were
delivered to the palm of the left hand (glabrous skin of the
thenar eminence) in 3 separate testing sessions on diﬀerent
days. The interval between stimuli was 3 seconds, with
stimulus duration (SD) of 1.0 seconds for series 1 and 3 and
0.8secondsforseries2and4.TheSDwastransitionedacross
4 pulses using increases or decreases of 0.4 seconds between
series (Figure 1).
Stimulation began with a 43◦C pulse, which was never
perceived as painful by any subject. The temperature then
increased from pulse to pulse in 1◦C increments until pain
intensity reached 10% on the electronic visual analog scale.
Thereafter, the temperature continued to rise at a reduced
rate (0.5◦C/pulse). This induction phase ended when the
pain intensity rating ﬁrst reached or exceeded the set point
of 35% on the eVAS. At that point bidirectional temperature
modulation commenced, maintaining a constant average
pain intensity level for the remainder of the series.
2.3. Measurement of Spontaneous Pain. At the beginning
of all experimental sessions, subjects were asked to shade
the locations and spatial extent of spontaneous pain on anPain Research and Treatment 3
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Figure 1: The stimulus duration alternated between 1.0 second (series 1 and 3) and 0.8 seconds (series 2 and 4). Within each series, the
temperature was modulated in a pain rating-dependent manner to maintain average pain intensity near a predetermined setpoint (35%).
The change in temperature needed to compensate for the change in stimulus duration or ISI served as response variable. Stimulus durations
are indicated above each bar, and interstimulus intervals remained constant at 3.0 seconds.
anatomical diagram and to rank these sites according to pain
intensity. Subsequently, the intensity of disease-related pain
of the upper body (head, neck, shoulder, upper back, arms,
and hands) and lower body (low back, bowel, legs, and feet)
were rated with the eVAS. The subjects were then asked to
rate the pain at the single most intense site. All these ratings
were required to be below 5% (on the 0–100% eVAS scale)
for subjects to be admitted to the control group.
2.4. Measurement of Skin Temperature. Skin temperatures
at both the stimulation site (left) and the corresponding
contralateral site (right) were measured with an Exergen
Dermatemp infrared temperature scanner model DT-1001
(Exergen Corp., Watertown, MA, USA) prior to, imme-
diately after, and 3 minutes following administration of
the four stimulus series. The temperature was scanned for
1-2 seconds, and the highest temperature reading during
this period was recorded. For testing associations between
skin temperature and pain sensitivity, two variables were
used; baseline temperature and maximum change in skin
temperatureatthenonstimulatedpalm,bothaveragedacross
three days of testing.
2.5. Statistical Methods. The GLM module of SPSS 17.0 was
used to test hypotheses. Correlation coeﬃcients between
ratings of clinical pain, baseline skin temperature, maximum
change in skin temperature at the nonstimulated palm, and
average probe temperature across the series were calculated
using Pearson Product Moment correlation coeﬃcients.
Because of the small samples involved, only correlations of
over .50 are reported.
Skin temperature diﬀerences between IBS patients and
healthy controls at the stimulated and nonstimulated palms
were tested using repeated measures analysis of variance
(ANOVA). The same analysis was also used to test group
diﬀerences in the stimulus temperatures needed to (a) ﬁrst
reach an eVAS rating of 10% and 35% and (b) maintain a
rating of 35% for each series. Bartlett’s test of sphericity of
the residual covariance matrix was used to test the sphericity
assumption. Greenhouse-Geisser adjustments were made
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Figure 2:Non-testedpalm.Averagetemperatures(ordinate)forthe
left and right palmar surfaces of control subjects and IBS patients
at 3 time points (abscissa). Compared to the resting level (time 1),
5 minutes of pain testing for control subjects signiﬁcantly reduced
skin temperature (time 2), with some recovery by 3 minutes (time
3). Resting skin temperatures did not diﬀer signiﬁcantly for IBS and
controlssubjects.Asigniﬁcantdecreaseinskintemperaturewasnot
produced by pain testing of IBS patients.
where appropriate. Paired-samples t-test using P = .01 as
the critical value was used for all pairwise comparisons.
3. Results
3.1. Ratings of IBS Pain. Ratings of the distribution and
magnitude of ongoing pain were obtained prior to each
testing session. Gut pain was rated as most severe on all but
1o c c a s i o nf o r3d i ﬀerent IBS patients, when upper extremity
pain was slightly greater than gut pain. Gut pain was rated
on test day 1 at an average of 28.5% (SD = 16.8, range = 3–
51), on day 2 at an average of 20.8% (SD = 23.9, range =
1–72), and on day 3 at an average of 22.2% (SD = 22.8, range
= 5–61). Thus, ongoing pain can be characterized overall as
mild to moderate, but it varied considerably from day to day
across the group of IBS patients.4 Pain Research and Treatment
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Figure 3: Mean thermode temperature by series. Thermode
temperatures (ordinate) averaged across 3 sessions of response-
dependent stimulation that maintained an average eVAS rating of
35 for pain intensity. Thermode temperatures are shown for 4
sequential series of 25 stimuli with durations of 1.0 second (series 1
and 3) and 0.8 seconds (series 2 and 4). Hyperalgesia for cutaneous
thermal stimulation was revealed by lower thermode temperatures
within each series.
Table 1: Mean and (SD) for palm temperature by group.
Time 1, Baseline
Time 2,
Immediately after
testing
Time 3, 3-minutes
after testing
(recovery)
Stimulated right palm
32.4 (1.0) 38.9 (1.0) 33.2 (1.6)
32.2 (1.1) 38.8 (1.3) 32.3 (0.8)
Nonstimulated left palm
32.4 (0.9) 32.1 (0.9) 32.0 (0.8)
32.2 (0.9) 30.7 (0.6) 31.2 (0.6)
3.2. Skin Temperature. Skin temperature at the thenar emi-
nence of both hands prior to thermal stimulation did not
diﬀer between IBS and control groups or between sessions.
At the stimulated palm, the results of a group × day ×
time ANOVA for skin temperatures indicated a signiﬁcant
main eﬀect of time (F = 165.973, P<. 001). As expected, a
higher mean temperature was found immediately following
the stimulus application than at baseline or following the
3-minute recovery period (both at P<. 001). The baseline
and recovery temperatures were not diﬀerent. There were no
other signiﬁcant main or interaction eﬀects. Table 1 presents
the mean temperatures by site and time for IBS patients and
controls, collapsed across days.
At the unstimulated palm, there was a substantial drop
in skin temperature that was detected immediately after
thermal stimulation, with partial recovery 3 minutes later.
There were signiﬁcant main eﬀects for group (F = 5.772,
P = .029) and time (F = 9.513, P = .001) and a signiﬁcant
group by time interaction (F = 4.028, P = .028). Testing
within groups to interpret the signiﬁcant interaction, the
Table 2: Mean temperature (SD) during each series for IBS and
controls.
Rating of
35%
Series 1
(SI = 1.0)
Series 2
(SI = 0.8)
Series 3
(SI = 1.0)
Series 4
(SI = 0.8)
48.6 (1.0) 47.5 (0.9) 46.5 (0.9) 46.0 (0.9) 46.4 (0.9)
51.6 (1.0) 50.7 (0.8) 51.0 (0.8) 50.0 (0.8) 50.5 (0.8)
3.0 3.2 4.5 4.0 4.1
unstimulated palmar temperatures for the control group
weresigniﬁcantlydiﬀerentacrosstimes1,2,and3(P<. 001).
There were no signiﬁcant diﬀerences across times 1–3 for the
unstimulatedpalmoftheIBSpatients.Thesedataareplotted
in Figure 2.
3.3. Response-Dependent Evaluation of Thermal Pain Sen-
sitivity. Thermode temperature diﬀerences associated with
initial pain ratings of 10% and 35% for the control and IBS
groups were tested using group × day ANOVA. Signiﬁcant
main eﬀects of group (F = 5.8498, P = .028) and ratings (F
(1, 16) = 30.687, P<. 001) were found. Controls required
a higher temperature to reach the pain rating criteria
than the IBS group (Table 2). As expected, a higher mean
temperaturewasassociated with therating of 35% compared
to 10%.
T h ea v e r a g et h e r m o d et e m p e r a t u r e sr e q u i r e dt om a i n -
tain a rating of 35% are shown in Figure 3 and Table 2 as a
function of pulse duration. A group × day × series repeated
measures ANOVA revealed a signiﬁcant main eﬀect of group
(F = 9.592, P = .007), as well as a group × series interaction
(F =3.234,P = .022).Thecontrolsusedhighertemperatures
forthe0.8CIseriescomparedtothe1.0CIseriesasexpected.
Mean thermode temperatures diﬀered for controls between
s e r i e s2a n d3( P<. 001) and series 3 and 4 (P<. 001).
The IBS group sensitized after the ﬁrst series, which diﬀered
from series 2 (P<. 01), series 3 (P<. 001), and series 4
(P<. 01).
3.4. Relationships between Clinical Pain, Skin Temperatures,
and Thermode Temperatures. For IBS patients, there were
no signiﬁcant associations between ratings of clinical pain
at the most painful site on the day of testing and resting
skin temperatures, skin temperatures at the unstimulated
palm after thermal pain testing, or thermode temperatures
that maintained 35% ratings. In contrast, thermode tem-
peratures for the IBS group were associated with baseline
skin temperatures (r = .74, P = .014) and with the
maximum change in skin temperature on the nonstimulated
palm (r = .52, P = .11). Resting skin temperatures,
skin temperature changes during stimulation, and ther-
mode temperatures were not signiﬁcantly correlated among
controls.
4. Discussion and Conclusions
Thepresentstudyfoundthatabnormalautonomicresponses
of IBS patients are revealed by painful somatic stimulationPain Research and Treatment 5
of a small area of the skin, as long as the stimulus is
of suﬃcient duration. Limitations of the study are that
the duration and intensity of the painful stimuli were not
systematically varied, and traditional autonomic response
measures (heart rate variability, blood pressure) were not
included, for comparison.
A repeated measures design was utilized for evaluation of
clinical pain ratings, skin temperatures, and psychophysical
ratings of thermal pain sensitivity across 4 series within 3
separate tests of a relatively homogeneous sample of IBS
patients. The participants with clinical pain were females
with IBS and diarrhea, and they were free from medications
that can confound studies of a chronic pain condition. These
characteristics should reduce the variability and diversity
that is inherent to most chronic pain conditions but is
problematic for correlational studies. For example, skin
temperature of females is highly responsive to sympathetic
vasoconstriction, a component of stress reactions which are
aﬀected by antidepressants often prescribed for chronic pain
[23]. Clinical pain intensity was rated thoroughly and at the
beginning of each test session so that it could be related
concurrently to autonomic reactivity and to somatic pain
sensitivity. This is important, because clinical pain intensity
changes over time in diﬀerent patterns for diﬀerent patients.
Psychophysical testing incorporated a method of repetitive
thermal stimulation which evaluated pain sensitivity as the
temperatures required to maintain the same average level
of pain for control subjects and IBS patients. Matching of
elicited pain across subjects is ideal when the intent is to
generate input of comparable aﬀective intensity to central
stress circuits.
Even though the group of IBS patients reported low
to moderate levels of chronic visceral pain, baseline skin
temperatures were not signiﬁcantly diﬀerent for IBS and
control subjects. However, resting skin temperature is not
controlled entirely by sympathetic tone. Responsivity to
environmental temperature by local vascular mechanisms
can compensate for a dysregulation of tonic sympathetic
outﬂow [42, 43]. As an alternative to measurement of resting
temperature, the magnitude of skin temperature decrements
in response to nociceptive stimulation can reveal tonic levels
of sympathetic activation, depending upon environmental
temperature and the subjects’ gender [14, 25, 38]. The key
to this physiological assay of sympathetic responsivity/tone
is to set the test conditions for stress-free subjects so that a
robustdecreaseinskintemperatureoccursduringprolonged
nociceptive stimulation. Given this responsivity for control
subjects, relatively high levels of tonic sympathetic activation
for IBS patients were revealed by a substantial reduction in
skintemperaturechange(byanaverageof80%)contralateral
to the hand receiving nociceptive stimulation. This ﬁnding
indicates that chronic IBS pain was associated with tonic
sympathetic vasoconstriction, which interfered with phasic
sympathetic activation during nociceptive stimulation. Sim-
ilar relationships between resting and elicited sympathetic
activity of IBS patients have been noted for heart rate
variability [12].
Despite a lack of between-group diﬀerences in rest-
ing skin temperatures, there was a signiﬁcant correlation
between resting skin temperatures and thermode temper-
atures during nociceptive testing of IBS patients. These
measures were not signiﬁcantly correlated for control sub-
jects, indicating that resting temperature was regulated by
diﬀerent means for control and IBS subjects. Sympathetic
tone appears to have determined resting skin temperatures
to a greater extent for IBS patients than for controls. The
relationship between skin temperatures and pain sensitivity
for IBS patients corroborates the between-group diﬀerence
in skin temperature change observed during nociceptive
thermal stimulation. These observations suggest that high
levels of tonic sympathetic tone for IBS patients induce ther-
mal hyperalgesia, elaborating upon previous demonstrations
of cutaneous hyperalgesia for IBS patients [2, 10, 27, 44].
However, levels of IBS pain were not signiﬁcantly correlated
with resting skin temperatures, skin temperature responses
to nociceptive stimulation, or thermal pain sensitivity. Thus,
elevated sympathetic tone is associated overall with chronic
IBS pain, but day-to-day variations in IBS pain magnitude
for the cohort of patients in this study were not dependent
upon levels of sympathetic tone or its inﬂuence on pain
sensitivity.
The vicious cycle of IBS pain and sympathetic dysreg-
ulation can be conceptualized in several ways, depending
on etiology: (1) stress-gut pathology and IBS pain-more
stress-more pain, and so forth; or (2) gut pathology and
IBS pain-stress-more pain-more stress, and so forth. Given
these reciprocal interactions, it is diﬃcult to determine the
cause of IBS pain, and it may not be a simple case of either
gut pathology or stress. For example, inﬂammation and
stress could interact to produce gut pathology [7, 25, 45].
Often,however,psychologicalconditionssuchasanxietyand
depression have been proposed as the initiating cause of IBS.
Relevant to this issue, psychological history has been found
to be unrelated to development of IBS [46]. In other studies,
correlations between psychological stress and concurrent
autonomic dysregulation or IBS pain have been nonexistent
or weak [3, 19, 47]. These ﬁndings and the present inves-
tigation cast doubt on the proposition that psychological
stress and an associated autonomic dysregulation deter-
mine IBS pain intensity. Also countering the psychogenic
hypothesis, there is considerable evidence that abnormal
aﬀerentinputfromthegutoriginatesandmaintainsIBSpain
[2].
If IBS pain results from gut pathology and sympathetic
dysregulation is a consequence of psychological reactions to
that pain and its implications for the individual, this has
important therapeutic implications. A cure for IBS pain is
expectedtodependupontreatmentsthataddressgutpathol-
ogy. In the absence of eﬀective gastrointestinal treatments of
IBS,reductionofstressandassociatedhyperalgesiashouldbe
beneﬁcial for management of pain.
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